carver no us sinus syndrome

Upload: uenyaeuenclubeveryday

Post on 09-Apr-2018

221 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/8/2019 Carver No Us Sinus Syndrome

    1/39

    Carvernous sinus syndrome

  • 8/8/2019 Carver No Us Sinus Syndrome

    2/39

    BackgroundCavernous sinus syndrome is defined by its resultant

    signs and symptoms: ophthalmoplegia, chemosis,

    proptosis, Horner syndrome, or trigeminal sensory

    loss. Infectious or noninfectious inflammatory,vascular, traumatic, and neoplastic processes are the

    principal causes.

    Examples of specific entities that may result in

    cavernous sinus syndrome are myriad and includecarotid artery aneurysms, carotid-cavernous fistulas

    (C-C fistulas), tumors, and Tolosa-Hunt syndrome, to

    name the most frequently discussed.

  • 8/8/2019 Carver No Us Sinus Syndrome

    3/39

    Pathophysiology

    The cavernous sinuses are paired, venous structures

    located on either side of the sella turcica. They

    receive venous tributaries from the superior and

    inferior orbital veins and drain into the superior andinferior petrosal sinuses. The cavernous sinus

    contains the carotid artery, its sympathetic plexus,

    and the oculomotor nerves (third, fourth, and sixth

    cranial nerves). In addition, the ophthalmic branchand occasionally the maxillary branch of the fifth

    nerve traverse the cavernous sinus. The nerves pass

    through the wall of the sinus while the carotid artery

    passes through the sinus itself.

  • 8/8/2019 Carver No Us Sinus Syndrome

    4/39

    Cavernous sinus tumors

    Cavernous sinus tumors are the most common cause

    of cavernous sinus syndrome. Tumors may be

    primary or may arise from either local spread or as

    metastases. Examples of primary tumors includemeningiomas or neurofibromas. Examples of locally

    spreading tumors are nasopharyngeal carcinoma or

    pituitary tumors. Metastatic lesions are most often

    from the breast, prostate, or lung. Radiotherapy mayoffer transient relief, particularly in nasopharyngeal

    cancer. Lateral extension of pituitary tumors may be

    treated with surgical resection and dopamine

    agonists in the case of prolactinoma. Total resection

  • 8/8/2019 Carver No Us Sinus Syndrome

    5/39

    Cavernous sinus aneurysms

    Unlike intracranial aneurysms in other anatomic

    locations, carotid-cavernous aneurysms do not

    involve a major risk of subarachnoid hemorrhage.

    However, their rupture can result in direct C-Cfistulas, which may lead to cerebral hemorrhage.

    These aneurysms, which are more frequent in the

    elderly population, present with an indolent

    ophthalmoplegia. Although some patients sufferminor disability and do not require treatment,

    endovascular occlusion of these lesions is often

    successful and may be attempted in selected

    patients.

  • 8/8/2019 Carver No Us Sinus Syndrome

    6/39

    Carotid-cavernous fistulas

    C-C fistulas are of 2 types: direct and indirect. Direct

    fistulas occur if the carotid artery and cavernous

    sinus are in continuity. They manifest with abrupt

    onset of proptosis, chemosis, visual loss, andophthalmoplegia. Indirect fistulas occur with

    communication between the cavernous sinus and the

    branches of the internal carotid artery, external

    carotid artery, or both.They have a more insidious presentation than direct

    fistulas, often with spontaneous resolution. Trauma or

    aneurysm rupture is a common cause of carotid-

    cavernous fistulas. Interventional radiologists can

  • 8/8/2019 Carver No Us Sinus Syndrome

    7/39

    Frequency

    In the US, approximately 5% of ophthalmoplegias are

    secondary to involvement of cranial nerves in the

    cavernous sinuses. This is probably true

    worldwide.Cavernous sinus aneurysms represent 5%of all intracranial aneurysms.

  • 8/8/2019 Carver No Us Sinus Syndrome

    8/39

    Mortality/

    Morbidity

    Most of the lesions affecting the cavernous sinuses are

    treatable.

    Metastatic cancer is a frequent cause of cavernous

    sinus syndromes, and the prognosis depends on thespecific tumor type.

    Cavernous sinus septic thrombophlebitis mortality has

    decreased from 100% to 20% with the

    implementation of improvement in diagnosis and

    therapeutics.

    Cavernous sinus aneurysms and C-C fistulas can be

    treated successfully by endovascular techniques.

  • 8/8/2019 Carver No Us Sinus Syndrome

    9/39

    Clinical

    The signs and symptoms frequently found in patients

    with cavernous sinus lesions include visual loss,

    proptosis, ocular and conjunctival congestion,

    elevation of ocular pressure, ophthalmoplegia, andpain. Various combinations of these symptoms may

    occur, which generally are unilateral, but may be

    bilateral with neoplastic processes.

    Symptoms may be acute or slowly progressive. Primarytumors are the most frequent neoplasm responsible

    for a cavernous sinus syndrome.

  • 8/8/2019 Carver No Us Sinus Syndrome

    10/39

    Cavernous sinus tumorsAcute or slowly progressive ophthalmoplegia is the

    dominant presentation, with diplopia being the

    most common symptom.

    At times, painful diplopia is present.Usually the patient has a preceding history of cancer.

    Occasionally, cavernous sinus syndrome is the first

    manifestation of a systemic neoplasm.

    Exophthalmos can be seen.

    If the tumor is a pituitary adenoma, endocrine

    symptoms and visual field deficits may be present.

  • 8/8/2019 Carver No Us Sinus Syndrome

    11/39

    Carotid-cavernous aneurysmsPatients frequently are elderly and present with

    subacute or chronic ophthalmoplegia.

    Rarely, they may have pain similar to that of

    trigeminal neuralgia.Spontaneous rupture of a carotid-cavernous

    aneurysm leads to an abrupt onset of a direct C-C

    fistula. This results in acute onset of massive

    exophthalmos with orbital, ocular, and conjunctival

    chemosis, binocular diplopia, and visual loss.

  • 8/8/2019 Carver No Us Sinus Syndrome

    12/39

    Two types of C-C fistulasDirect fistulas present with prominent acute

    symptoms.

    Conversely, indirect fistulas are characterized by

    mild proptosis, chronic diplopia, drooping of the lid,a red eye, arterialization of the conjunctival

    vessels, and visual loss. The patient may report

    subjective "noises" in his or her head.

  • 8/8/2019 Carver No Us Sinus Syndrome

    13/39

    Cavernous sinus thrombosisThis is infrequent in the postantibiotic era.

    It may occur as a complication of infection in the

    ethmoid, sphenoid, or frontal sinuses or from

    midfacial, dental, or orbital infections.Patients may present with sepsis or metastatic

    spread of septic emboli, most commonly

    occurring in the lung. This presentation may

    appear as acute respiratory distress syndrome

    (ARDS).

    Retrobulbar pain, drooping of the upper eyelid, and

    diplopia may be the first symptoms indicating thelesion's extension to the cavernous sinus.

  • 8/8/2019 Carver No Us Sinus Syndrome

    14/39

    Miscellaneous inflammatory lesionsThese may involve the cavernous sinuses or the

    walls of the sinus.

    Herpes zoster in its acute or chronic stage rarely

    causes pain, diplopia, and a droopy eyelid inaddition to the typical zoster blisters. In the chronic

    stage, a scar from the acute lesion usually is

    found.

    An idiopathic inflammation of the walls of the

    cavernous sinuses is referred to as Tolosa-Hunt

    syndrome.

    Sarcoid or Wegener granulomatosis may alsoredis ose to cavernous sinus s ndrome.

  • 8/8/2019 Carver No Us Sinus Syndrome

    15/39

    Physical

    Cavernous sinus lesions are characterized by thefollowing signs:

    Unilateral and isolated third, fourth, or sixth cranial

    nerve palsyCombination patterns of ophthalmoplegia

    Painful ophthalmoplegia

    Proptosis (pulsating exophthalmos suggests a direct

    C-C fistula)Ocular and cranial bruits

    Conjunctival congestion; arterialization ofconjunctival veins

    Ocular hypertension

  • 8/8/2019 Carver No Us Sinus Syndrome

    16/39

    Anesthesia in the ophthalmic division of thetrigeminal nerve (V1) and/or decreased or absentcorneal reflex and possibly anesthesia in themaxillary or V2 branch

    Pupil in midposition and nonreactive if bothsympathetics and parasympathetics from the thirdnerve are affected

    Cavernous sinus tumors

    Metastatic lesions - Isolated or combinedophthalmoplegia, painful ophthalmoplegia,anesthesia in the ophthalmic nerve

    Pituitary tumors - Isolated or combinedophthalmoplegia (lateral extension); endocrine

    signs such as acromegaly, galactorrhea, and

  • 8/8/2019 Carver No Us Sinus Syndrome

    17/39

    Cavernous sinus aneurysms

    Isolated or combined ophthalmoplegia

    Painful ophthalmoplegia

    Decreased pain sensation in the V1 ophthalmic

    divisionCarotid-cavernous fistulas

    Direct - Unilateral massive proptosis, pulsatingexophthalmos, lid congestion, conjunctival

    chemosis, orbital congestion, ocular hypertension,visual loss, optic neuropathy, optic disc edema,retinal hemorrhages, retinal venous congestion,and loud ocular and cranial bruit

    Indirect -S

    imilar signs and symptoms of lesserseverit occasionall isolated o hthalmo le ia

  • 8/8/2019 Carver No Us Sinus Syndrome

    18/39

    Cavernous sinus thrombosisGenerally speaking, primary infectious process

    involving paranasal sinuses and/or orbital cellulitis

    In addition to local and systemic signs of infection,

    the following may be seen:Isolated or combined ophthalmoplegia

    Painful ophthalmoplegia

    Orbital congestion, lid chemosis, proptosisVisual loss, optic disc edema (unilateral)

    Signs of meningeal irritation

  • 8/8/2019 Carver No Us Sinus Syndrome

    19/39

    Miscellaneous cavernous sinus lesionsTolosa-Hunt syndrome - Isolated or combined,

    painful ophthalmoplegia

    Herpes zoster - Acute zoster ophthalmicus, typical

    skin lesion, and keratitisSarcoidosis - Systemic signs, uveitis,

    ophthalmoplegia, facial diplegia

  • 8/8/2019 Carver No Us Sinus Syndrome

    20/39

    Causes

    Metastatic tumors

    Breast

    Prostate

    Lung

    Localized spread of tumor

    Nasopharyngeal

    Pituitary

  • 8/8/2019 Carver No Us Sinus Syndrome

    21/39

    Primary intracranial tumorsMeningiomas

    Neurofibromas

    Chondromas (less common)

    Trauma (including postsurgical)

    Carotid-cavernous aneurysms

    Carotid-cavernous fistulas

    Cavernous sinus thrombosis

  • 8/8/2019 Carver No Us Sinus Syndrome

    22/39

    Miscellaneous inflammatory syndromesHerpes zoster

    Tolosa-Hunt syndrome

    Sarcoidosis

  • 8/8/2019 Carver No Us Sinus Syndrome

    23/39

    Differentials Aneurysms involving posteriorcommunicating artery with painful ophthalmoplegia

    Orbital pseudotumor

    Basilar artery aneurysm

    Paranasal sinus lesions (particularly in sphenoidsinus)

    Causes of cisternal third, fourth, and sixth nerve

    palsies, including basilar meningitides

    Thyroid eye diseaseIntra-axial brainstem lesions associated with isolated

    ophthalmoplegia

    Tumors and other lesions in the middle cranial fossa

    Lesions involving orbital apex, especially in and

  • 8/8/2019 Carver No Us Sinus Syndrome

    24/39

    Diagnostic Workup

    Patients in whom cavernous sinus lesions aresuspected should undergo thin-section multiplanarimaging studies of the orbit and the sellar/parasellarregion. Precontrast and postcontrast scans are

    advisable. CT scan offers better visualization of boneand calcium. However, MRI provides better detail ofall soft tissues contained in the sinuses, the expectedsignal void of the normal carotid artery, and its

    relation to the surrounding structures.Orbital views are necessary to exclude a disease

    process primarily involving the cavernous sinuseswith concomitant compromise of the orbital apex.

    Conversely, primary orbit and paranasal sinus

  • 8/8/2019 Carver No Us Sinus Syndrome

    25/39

    Cavernous sinus tumors

    In the case of metastatic tumors, diagnosis of the

    primary neoplasm generally precedes the cavernous

    sinus syndrome.

    A lumbar puncture with cytologic examination may behelpful.

    If a primary neoplasm of the nasopharynx is suspected,

    a biopsy may be needed.

    In the case of pituitary tumors with lateral extension,

    tumor resection may be necessary.

    Rarely, a biopsy of the cavernous sinus tumor is

    needed for diagnosis.

  • 8/8/2019 Carver No Us Sinus Syndrome

    26/39

    Cavernous sinus aneurysms

    As MRI and/or magnetic resonance angiography (MRA)

    are often specific, cerebral angiography generally is

    not required to make a diagnosis.

    Perform angiography if balloon occlusion of theaneurysm is planned.

  • 8/8/2019 Carver No Us Sinus Syndrome

    27/39

    Carotid-cavernous fistulas

    The dramatic clinical presentation and MRI and/or MRA

    of direct fistulas leave little doubt regarding the

    diagnosis.

    By contrast, indirect fistulas, particularly those drainingin the petrosal sinuses, are associated with subtle

    findings and possibly a normal MRI and/or MRA.

    Cerebral angiography is the only way to arrive at the

    correct diagnosis.

    Perform angiography to stage the fistula and document

    the anterior and posterior drainage routes.

  • 8/8/2019 Carver No Us Sinus Syndrome

    28/39

    C

    avernous sinus thrombosisImaging of the orbit and/or nasal sinuses is helpful in

    the search for a septic focus.

    An aseptic thrombosis may be associated with

    conditions such as hypercoagulable states andlymphoproliferative disorders.

    A hematologic workup is indicated in these patients.

  • 8/8/2019 Carver No Us Sinus Syndrome

    29/39

    Miscellaneous inflammatory syndromes

    Investigate additional systemic inflammatory and

    granulomatous processes after other common

    causes have been excluded. These disorders can be

    screened by studies such as laboratory tests andchest x-ray.

    Tolosa-Hunt syndrome (an uncommon, idiopathic,

    inflammatory cavernous sinus syndrome) may share

    a close etiologic link with orbital pseudotumor.A nonspecific fibrotic inflammatory reaction and

    rarely a granulomatous inflammation can occur,

    but biopsy is rarely used to establish the diagnosis.

    A ositive res onse to steroids is considered

  • 8/8/2019 Carver No Us Sinus Syndrome

    30/39

    Biopsy of the cavernous sinuses entails a craniotomy,which is associated with morbidity. Restrict acraniotomy to patients with a documented,progressive cavernous sinus syndrome.

    Treatment Cavernous sinus tumors

    Metastatic lesionsRadiotherapy may offer transient improvement.

    Nasopharyngeal carcinomas may be veryradiosensitive, with a prolonged remissionfollowing treatment.

    Pituitary tumors

    Prolactinomas may improve with oral dopamineagonists, or they may require resection.

    Gamma knife ma be an ad unctive treatment for

  • 8/8/2019 Carver No Us Sinus Syndrome

    31/39

    Cavernous sinus meningiomas

    These lesions represent a major challenge for

    surgical resection, primarily because of poor

    accessibility and the frequent encasement of the

    cavernous carotid artery.Since these tumors are slow growing and difficult to

    resect, elderly patients or those with minor

    symptoms probably should be observed

    expectantly without specific treatment.Radiotherapy may be offered to some patients, and

    some show improvement of cranial nerve function

    after gamma knife treatment. Partial resection may

    be attempted in others with disabling symptoms

  • 8/8/2019 Carver No Us Sinus Syndrome

    32/39

    Cavernous sinus aneurysms

    Treat cavernous sinus aneurysms by endovascularballoon occlusion.

    Carotid-cavernous fistulas Treatment ideallyconsists of endovascular obliteration of the fistulawith coils, although some cavernous sinus dural AVfistulas may be observationally managed.

    Access to the fistula may be transarterial; however, thetransvenous approach has become the mainstay of

    treatment, in some cases a combinedsurgical/endovascular approach can be used withsurgical exposure of the superior ophthalmicvein followed by fistula embolization. Several venous

    approaches have been used, including the safest

  • 8/8/2019 Carver No Us Sinus Syndrome

    33/39

    Percutaneous transorbital access to the cavernous

    sinus followed by embolization.

    Small indirect C-C fistulas may occlude either

    spontaneously or following diagnostic angiography. If

    the clinical signs are mild, consider carefulmonitoring.

    If intraocular pressure is elevated, antiglaucoma agents

    may be required.

  • 8/8/2019 Carver No Us Sinus Syndrome

    34/39

    Cavernous sinus thrombosis

    High-dose antibiotic therapy should be directed

    against the most common pathogens, such as S

    aureus and S pneumoniae, as well as gram-negative

    rods and anaerobes.Anticoagulation in septic cavernous sinus thrombosis is

    controversial, but may hasten the rate of recovery.

    Drainage of any primary site of infection (eg, abscess,

    sinusitis) is advised.Corticosteroids are not recommended.

    Anticoagulation also may be helpful in aseptic patients.

  • 8/8/2019 Carver No Us Sinus Syndrome

    35/39

    Miscellaneous inflammatory syndromes

    Inflammatory cavernous sinus syndromes may

    respond to treatment of the specific systemic

    inflammation or vasculitic etiology.

    Tolosa-Hunt syndrome responds well to a 3- to 6-monthcourse ofhigh-dose steroid therapy that can be

    tapered slowly thereafter.

    Keywords

    parasellar lesions, cavernous sinus, tumors, carotidartery aneurysms, carotid-cavernous fistulas, C-C

    fistulas, cavernous sinus syndrome, ophthalmoplegia,

    chemosis, proptosis, Horner syndrome, Horner's

    syndrome, trigeminal sensory loss, cavernous sinus

  • 8/8/2019 Carver No Us Sinus Syndrome

    36/39

  • 8/8/2019 Carver No Us Sinus Syndrome

    37/39

  • 8/8/2019 Carver No Us Sinus Syndrome

    38/39

  • 8/8/2019 Carver No Us Sinus Syndrome

    39/39